Skip to main content

ORIGINAL RESEARCH article

Front. Pharmacol.
Sec. Gastrointestinal and Hepatic Pharmacology
Volume 15 - 2024 | doi: 10.3389/fphar.2024.1452201

Construction of an Interpretable Model for Predicting Survival Outcomes in Patients with Advanced Hepatocellular Carcinoma (≥5cm in Diameter) Using Lasso-Cox Regression

Provisionally accepted
Han Li Han Li 1Bo Yang Bo Yang 1Chenjie Wang Chenjie Wang 1Bo Li Bo Li 1Lei Han Lei Han 2Yi Jiang Yi Jiang 1Yanqiong Song Yanqiong Song 3Lianbin Wen Lianbin Wen 4Mingyue Rao Mingyue Rao 1Zhang Jianwen Zhang Jianwen 1Xueting Li Xueting Li 5Kun He Kun He 1Yunwei Han Yunwei Han 1*
  • 1 The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, China
  • 2 Affiliated Hospital of Jining Medical University, Jining, Shandong Province, China
  • 3 Radiation Oncology Key Laboratory of Sichuan Province, Sichuan Cancer Hospital, Chengdu, Sichuan Province, China
  • 4 Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital, Chengdu, Sichuan Province, China
  • 5 AVIC 363 Hospital, Chengdu, Sichuan Province, China

The final, formatted version of the article will be published soon.

    Background: In this retrospective study, we aimed to identify key risk factors and establish an interpretable model for HCC with a diameter ≥ 5cm using Lasso regression for effective risk stratification and clinical decision-making. Methods: In this study, 843 patients with advanced hepatocellular carcinoma(HCC) and tumor diameter ≥ 5cm were included. Using Lasso regression to screen multiple characteristic variables, cox proportional hazard regression and random survival forest models(RSF) were established. By comparing the area under the curve (AUC), the optimal model was selected. The model was visualized, and the order of interpretable importance was determined. Finally, risk stratification was established to identify patients at high risk. Result: Lasso regression identified 8 factors, including BCLC staging, as characteristic risk factors. Subsequent analysis revealed that the lasso-cox model had AUC values of 0.773, 0.758, and 0.799, while the lasso-RSF model had AUC values of 0.734, 0.695, and 0.741, respectively. Based on these results, the lasso-cox model was chosen as the superior model. Interpretability assessments using SHAP values indicated that the most significant characteristic risk factors, in descending order of importance, were tumor number, BCLC stage, alkaline phosphatase(ALP), ascites, albumin(ALB), and aspartate aminotransferase(AST). Additionally, through risk score stratification and subgroup analysis, it was observed that the median OS of the low-risk group was significantly better than that of the middle-and high-risk groups.We have developed an interpretable predictive model for middle and late HCC with tumor diameter ≥ 5cm using lasso-cox regression analysis. This model demonstrates excellent prediction performance and can be utilized for risk stratification.

    Keywords: LASSO-COX, nomogram, Interpretable, Hepatocellular Carcinoma, Radiotherapy

    Received: 20 Jun 2024; Accepted: 04 Sep 2024.

    Copyright: © 2024 Li, Yang, Wang, Li, Han, Jiang, Song, Wen, Rao, Jianwen, Li, He and Han. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Yunwei Han, The Affiliated Hospital of Southwest Medical University, Luzhou, 646000, Sichuan, China

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.